Application of a CXCR3 antagonist inhibited inflammatory cell migration leading to reduced lesion size of the apical periodontitis (Hasegawa et al., 2021), clearly implying a crucial role for the CXCL9-CXCR3 cascade in early inflammation. Here, CXCL9 is linked to periapical periodontitis.